Caligan Partners LP is Director & 10% Owner at Liquidia Corp (LQDA). They have made 15 open-market trades across 3 companies since 2022, most recently 2026-05-19.
CIK 0001727492
13 open-market purchases totalling $54.4M since 2022, against 2 sales. Across 13 scored buys the stock is up 5.7% at ninety days, and 4.1 points ahead of the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| LQDA | 8,138,951 | $279.4M |
| EXEL | 1,553,262 | $96.6M |
| LAB | 8,576,799 | $5.4M |
| Total | $381.5M |
Shares reported on the most recent Form 4, priced at the 2026-05-20 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 46% | 62% | 54% |
| Avg Move | -2.3% | +1.0% | +5.7% |
| Alpha | -2.6% | +2.6% | +4.1% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LQDA | SELL | 2026-05-19 | 2026-05-20 | $59.98 | $318K | -9.3% | +24.2% | +22.3% |
| LQDA | BUY | 2026-05-19 | 2026-05-20 | $59.98 | $318K | -9.3% | +24.2% | +22.3% |
| EXEL | BUY | 2025-11-25 | 2025-11-26 | $43.12 | $2.4M | -6.8% | +3.0% | +0.5% |
| LQDA | BUY | 2024-08-30 | 2024-09-04 | $9.51 | $1.4M | +11.5% | +11.8% | +25.5% |
| EXEL | BUY | 2024-02-21 | 2024-02-22 | $20.70 | $3.9M | +4.6% | +11.3% | -1.4% |
| LQDA | BUY | 2023-12-14 | 2023-12-14 | $7.16 | $16.0M | +63.0% | +65.5% | +96.9% |
| EXEL | BUY | 2023-11-27 | 2023-11-29 | $21.61 | $5.2M | +3.1% | +12.2% | +1.5% |
| EXEL | SELL | 2023-11-27 | 2023-11-29 | $21.61 | $2.6M | +3.1% | +12.2% | +1.5% |
| LAB | BUY | 2022-06-13 | 2022-06-15 | $1.70 | $170K | -2.2% | -15.6% | -20.7% |
| LQDA | BUY | 2022-05-25 | 2022-05-26 | $3.40 | $270K | +9.4% | +10.9% | +84.2% |
| LQDA | BUY | 2022-05-17 | 2022-05-19 | $5.87 | $2.2M | -34.6% | -21.0% | +21.0% |
| LAB | BUY | 2022-05-06 | 2022-05-10 | $2.88 | $1.4M | -21.1% | -21.9% | -17.4% |
| LQDA | BUY | 2022-04-18 | 2022-04-18 | $5.10 | $18.0M | +7.2% | +5.6% | -29.8% |
| LAB | BUY | 2022-04-11 | 2022-04-13 | $3.80 | $741K | -28.2% | -37.5% | -54.9% |
| LAB | BUY | 2022-04-06 | 2022-04-08 | $3.74 | $2.3M | -27.0% | -36.1% | -54.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.